GISONDI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 17.716
EU - Europa 14.018
AS - Asia 10.066
SA - Sud America 1.683
Continente sconosciuto - Info sul continente non disponibili 477
AF - Africa 448
OC - Oceania 80
AN - Antartide 1
Totale 44.489
Nazione #
US - Stati Uniti d'America 16.991
RU - Federazione Russa 4.983
SG - Singapore 4.352
IT - Italia 3.097
CN - Cina 2.203
GB - Regno Unito 2.068
BR - Brasile 1.341
HK - Hong Kong 933
VN - Vietnam 874
DE - Germania 672
FR - Francia 647
IE - Irlanda 640
SE - Svezia 558
FI - Finlandia 496
KR - Corea 330
CA - Canada 321
BD - Bangladesh 303
IN - India 213
NL - Olanda 151
TR - Turchia 147
UA - Ucraina 145
ES - Italia 140
ID - Indonesia 138
AR - Argentina 105
MX - Messico 101
JP - Giappone 97
IQ - Iraq 77
NG - Nigeria 75
PL - Polonia 75
TG - Togo 72
ZA - Sudafrica 69
AU - Australia 68
EC - Ecuador 63
AT - Austria 59
BJ - Benin 57
CR - Costa Rica 56
IL - Israele 54
CO - Colombia 43
PK - Pakistan 40
CH - Svizzera 39
SA - Arabia Saudita 39
BE - Belgio 37
SV - El Salvador 35
MY - Malesia 33
CL - Cile 32
GT - Guatemala 32
CW - ???statistics.table.value.countryCode.CW??? 31
EG - Egitto 31
UZ - Uzbekistan 31
HN - Honduras 30
MA - Marocco 30
TT - Trinidad e Tobago 29
IR - Iran 27
JM - Giamaica 27
LT - Lituania 26
VE - Venezuela 26
NI - Nicaragua 25
PY - Paraguay 25
PR - Porto Rico 24
PH - Filippine 23
KE - Kenya 21
AL - Albania 20
DZ - Algeria 19
BO - Bolivia 18
TN - Tunisia 18
KZ - Kazakistan 17
SC - Seychelles 17
DK - Danimarca 16
PE - Perù 16
CZ - Repubblica Ceca 15
NP - Nepal 15
RO - Romania 15
EE - Estonia 14
HU - Ungheria 14
PT - Portogallo 14
HR - Croazia 13
JO - Giordania 12
UY - Uruguay 12
AZ - Azerbaigian 11
GR - Grecia 11
TH - Thailandia 11
NZ - Nuova Zelanda 10
AE - Emirati Arabi Uniti 9
BG - Bulgaria 9
ET - Etiopia 9
TW - Taiwan 9
BY - Bielorussia 8
DO - Repubblica Dominicana 8
GP - Guadalupe 8
MM - Myanmar 8
LB - Libano 7
GD - Grenada 6
GE - Georgia 6
GH - Ghana 6
IS - Islanda 6
LK - Sri Lanka 6
OM - Oman 6
AO - Angola 5
LV - Lettonia 5
ME - Montenegro 5
Totale 43.941
Città #
Ashburn 2.688
Singapore 2.221
San Jose 1.808
Moscow 1.552
Southend 1.530
Dallas 1.380
Chandler 1.036
Jacksonville 933
Hong Kong 912
Council Bluffs 772
Dublin 628
Verona 551
Woodbridge 541
Houston 440
Ann Arbor 407
The Dalles 397
Beijing 381
Ho Chi Minh City 318
New York 318
Milan 278
Los Angeles 275
Santa Clara 226
Rome 224
Wilmington 218
Princeton 211
Lawrence 209
Hanoi 198
Helsinki 159
Munich 149
Buffalo 141
São Paulo 137
Jinan 131
Nanjing 130
Redondo Beach 127
London 116
Chicago 99
Shenyang 98
Sindelfingen 91
Jakarta 80
Atlanta 77
Phoenix 73
Lomé 72
Bologna 71
Tianjin 71
Frankfurt am Main 68
Montreal 67
Naples 67
Abuja 66
Hebei 63
Toronto 63
Lappeenranta 62
Tokyo 61
Orem 59
Seattle 58
Washington 58
Cotonou 57
Guangzhou 57
Brooklyn 56
Haikou 53
Changsha 52
North Bergen 51
Warsaw 51
Amsterdam 49
Columbus 49
Turin 49
Chennai 47
Madrid 47
San José 45
McKinney 43
Nanchang 43
Redwood City 42
Boardman 41
Hangzhou 41
Florence 40
Haiphong 40
Rio de Janeiro 40
Johannesburg 37
San Francisco 37
Zhengzhou 37
Belo Horizonte 36
Da Nang 36
Brasília 35
Denver 35
Vienna 35
Las Vegas 34
Mexico City 34
Jiaxing 32
Nuremberg 32
Shanghai 32
Venice 31
Willemstad 31
Boston 30
Brussels 29
Falls Church 29
Kent 29
Kuala Lumpur 29
Manchester 29
San Salvador 29
Cleveland 28
Curitiba 28
Totale 24.933
Nome #
Pemfigoide cicatriziale di Brunsting-Perry: descrizione di un caso. 687
Heat urticaria: a revision of published cases with an update on classification and management 535
Il ruolo della vitamina D nella dermatite atopica 468
Interstitial granulomatous dermatitis: a distinct entity withcharacteristic histological and clinical pattern 460
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review 402
La “Cross Unit”, una nuova modalità per ottimizzare il trattamento topico della psoriasi 387
A systematic review of treatments for pityriasis lichenoides 357
A new instrument for the screening of psoriatic arthritis among psoriatic patients 348
Dietary supplements for lipedema 335
A itchy vesiculobullous eruption in a patient with chronic lymphocytic leukemia. 227
Annually Recurring Erythema Annulare Centrifugum: A New Case Series with Review of the Literature 225
Advanced Glycation End Products in the Pathogenesis of Psoriasis 212
Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis 210
Gender perspective in the management of psoriasis 207
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 199
Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy 196
Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study. 194
Annular Lichenoid Dermatitis of Youth: Report of Six New Cases with Review of the Literature 194
Acneiform eruption induced by cetuximab 184
Retention rate of systemic drugs in patients with chronic plaque psoriasis 184
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products 183
State of the art and pharmacological pipeline of biologics for chronic plaque psoriasis. 182
Incidence of Adverse Cutaneous Reactions to Epidermal Growth Factor Receptor Inhibitors in Patients with Non-Small-Cell Lung Cancer 181
Main nutritional deficiencies 180
Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. 180
Balneotherapy for chronic plaque psoariasis at Comano spa in Trentino, Italy. 180
Polymorphisms, diet and nutrigenomics 179
Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. 179
H1 histamine receptor mediates inflammatory responses in human keratinocytes. 178
Erythema nodosum: etiological factors and relapses in a retrospective cohort study. 177
Lebbra lepromatosa. 176
Complicanze dell'obesità: la cute 175
Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial 171
The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis 171
Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis 171
Psoriasin (S100A7) is increased in serum of patients with moderate to severe psoriasis 171
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis 171
Lower limbs enthesopathy in psoriasic patients without clinical signs of arthropathy: a bospital based case-control study. 170
A randomized controlled trial to evaluate short-term treatment with eosin vs. topical steroids in psoriasis. 170
Vitamin D levels in patients with psoriasis with or without arthritis 168
Low dose acitretin versus methotrexate in the treatment of palmoplantar psoriasis: a case series. 167
Impact of the COVID-19 pandemic on melanoma diagnosis 167
Nonalcoholic fatty liver disease in patients with chronic plaque psoriasis. 167
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid 167
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 166
Incidence of respiratory and allergic symptoms in Italian and immigrant children 166
Psoriasis, the liver, and the gastrointestinal tract 165
Impact of TNF-α antagonists on the quality of life in selected skin diseases 165
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature 165
Targeting TNF-a in psoriasis and psoriatic arthritis. 163
A dermatologist perspective in the pharmacological treatment of patients with psoriasis and psoriatic arthritis 163
Psoriasis and the metabolic syndrome 163
Squamous cell carcinoma arising in lupus vulgaris. 162
Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis 162
Steatosi epatica non alcolica in pazienti con psoriasi cronica in placche. 162
Balneotherapy for atopic dermatitis in children at Comano spa in Trentino, Italy 162
Psoriatic Arthritis and Diabetes Mellitus: A Narrative Review 162
Aggiornamento sulla terapie biologiche della psoriasi 161
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 161
Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observation 160
C-reactive protein and markers for thrombophilia in patients with chronic plaque psoriasis 158
Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis 158
Psoriasi. Una guida per una migliore gestione del paziente. 157
Vitamin D status in patients with chronic plaque psoriasis 157
Attitude to treatment of patients with psoriasis attending SPA center 157
Image Gallery: Pyoderma gangrenosum of the penis. 157
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach 156
Pimecrolimus in dermatology: atopic dermatitis and beyond. 156
The metabolic syndrome in psoriasis 156
TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis 156
Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study. 155
Ki67/MART1 and p63/SOX10 Dual Immunohistochemistry Allows a Correct Interpretation of the Melanocytic Component in the Diagnosis of Pigmented Pilomatricoma 155
Considerations for Systemic Treatment of Psoriasis in Obese Patients 153
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations 153
Severe impairment of quality of life in Hailey-Hailey disease. 152
The efficacy and safety of topical pimecrolimus in pediatric patients with atopic dermatitis. 152
Tossicodermia indotta da oxcarbamazepina: descrizione di un caso. 151
Chronic plaque psoriasis is associated with increased arterial stiffness 148
Phenotypes of atopic dermatitis 148
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry. 148
The expectations of patients with psoriasis during an office consultation 148
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis 147
Advanced Glycation End Products and Psoriasis 147
Effects of secukinumab on serum adipocytokines: preliminary data 147
The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. 146
Efficacy and safety of secukinumab in chronic plaque psoriasis and psoriatic arthritis therapy 146
Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study 145
Prevalence of symptoms experienced by patients with different clinical types of psoriasis. 145
Metabolic comorbidities and psoriasis. 145
Dermatite atopica. 143
Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008. 143
Systemic therapy of psoriasis in diabetic patients 143
Switching patterns of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network 141
Uncommon Non‑Infectious Annular Dermatoses 141
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis 141
Pretibial Dystrophic Epidermolysis Bullosa Successfully Treated with Upadacitinib: A Case Report 141
Diabetes and the Skin 141
Dermoscopic features of nevoid melanoma: a retrospective study 140
The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis 140
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study 139
Totale 18.952
Categoria #
all - tutte 162.750
article - articoli 157.808
book - libri 491
conference - conferenze 0
curatela - curatele 0
other - altro 394
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.057
Totale 325.500


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022938 0 0 0 0 87 85 54 106 77 55 119 355
2022/20233.787 261 234 348 593 265 869 65 191 497 213 179 72
2023/20242.505 117 194 235 278 259 399 148 156 35 108 339 237
2024/20256.482 377 341 228 1.025 355 296 414 307 924 459 572 1.184
2025/202618.518 1.394 902 1.647 2.637 4.304 1.106 1.749 1.195 1.377 978 533 696
2026/20275.349 847 690 843 2.734 235 0 0 0 0 0 0 0
Totale 44.489